2018 Q1 Form 10-Q Financial Statement
#000120179218000006 Filed on May 08, 2018
Income Statement
Concept | 2018 Q1 | 2017 Q4 | 2017 Q1 |
---|---|---|---|
Revenue | $74.97M | $78.09M | $75.69M |
YoY Change | -0.95% | -0.69% | -9.86% |
Cost Of Revenue | $29.69M | $28.65M | $28.96M |
YoY Change | 2.51% | -4.66% | -2.52% |
Gross Profit | $45.28M | $49.44M | $46.73M |
YoY Change | -3.1% | 1.77% | -13.88% |
Gross Profit Margin | 60.4% | 63.32% | 61.74% |
Selling, General & Admin | $34.47M | $31.65M | $33.19M |
YoY Change | 3.85% | -2.53% | 0.16% |
% of Gross Profit | 76.12% | 64.02% | 71.03% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $4.520M | $4.620M | $4.740M |
YoY Change | -4.64% | -2.94% | -3.07% |
% of Gross Profit | 9.98% | 9.34% | 10.14% |
Operating Expenses | $34.47M | $36.26M | $33.19M |
YoY Change | 3.85% | -2.58% | 0.16% |
Operating Profit | $6.162M | $13.18M | $8.307M |
YoY Change | -25.82% | 16.02% | -47.98% |
Interest Expense | $493.0K | $140.0K | $11.00K |
YoY Change | 4381.82% | 1300.0% | -70.27% |
% of Operating Profit | 8.0% | 1.06% | 0.13% |
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | $6.655M | $12.78M | $8.318M |
YoY Change | -19.99% | 13.48% | -48.04% |
Income Tax | $1.865M | $5.530M | $3.849M |
% Of Pretax Income | 28.02% | 43.28% | 46.27% |
Net Earnings | $4.589M | $8.417M | $4.509M |
YoY Change | 1.77% | 22.11% | -56.39% |
Net Earnings / Revenue | 6.12% | 10.78% | 5.96% |
Basic Earnings Per Share | $0.28 | $0.52 | $0.28 |
Diluted Earnings Per Share | $0.28 | $0.51 | $0.28 |
COMMON SHARES | |||
Basic Shares Outstanding | 16.36M shares | 16.27M shares | 16.19M shares |
Diluted Shares Outstanding | 16.53M shares | 16.32M shares |
Balance Sheet
Concept | 2018 Q1 | 2017 Q4 | 2017 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $186.2M | $179.2M | $147.8M |
YoY Change | 25.98% | 22.4% | 23.17% |
Cash & Equivalents | $186.2M | $179.2M | $147.8M |
Short-Term Investments | |||
Other Short-Term Assets | $7.400M | $4.800M | $7.400M |
YoY Change | 0.0% | -9.43% | -36.21% |
Inventory | |||
Prepaid Expenses | $7.409M | $4.792M | $7.397M |
Receivables | $7.924M | $7.136M | $6.200M |
Other Receivables | $0.00 | $0.00 | $4.200M |
Total Short-Term Assets | $201.5M | $191.1M | $165.6M |
YoY Change | 21.65% | 20.49% | 17.34% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $90.25M | $95.25M | $95.73M |
YoY Change | -5.73% | -2.5% | -11.37% |
Goodwill | $33.90M | $33.90M | $33.90M |
YoY Change | 0.0% | 0.0% | -12.26% |
Intangibles | $4.606M | ||
YoY Change | -11.49% | ||
Long-Term Investments | $12.30M | $12.48M | $14.65M |
YoY Change | -16.05% | -14.58% | -16.11% |
Other Assets | $8.304M | $6.276M | $8.305M |
YoY Change | -0.01% | -27.83% | -9.06% |
Total Long-Term Assets | $144.7M | $147.9M | $154.7M |
YoY Change | -6.43% | -5.79% | -10.71% |
TOTAL ASSETS | |||
Total Short-Term Assets | $201.5M | $191.1M | $165.6M |
Total Long-Term Assets | $144.7M | $147.9M | $154.7M |
Total Assets | $346.2M | $339.0M | $320.3M |
YoY Change | 8.09% | 7.42% | 1.88% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $4.952M | $8.844M | $4.837M |
YoY Change | 2.38% | 29.05% | -32.55% |
Accrued Expenses | $15.74M | $3.621M | $11.82M |
YoY Change | 33.18% | -74.36% | -34.09% |
Deferred Revenue | $19.75M | $19.37M | |
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $45.32M | $43.35M | $39.83M |
YoY Change | 13.78% | 2.79% | -21.91% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $45.32M | $43.35M | $39.83M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $52.45M | $49.63M | $51.20M |
YoY Change | 2.45% | -2.59% | -23.61% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $108.3M | $108.6M | $91.96M |
YoY Change | 17.76% | 24.15% | 24.89% |
Common Stock | $180.9M | $180.8M | $177.2M |
YoY Change | 2.11% | 2.04% | 1.97% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $293.8M | $289.4M | $269.1M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $346.2M | $339.0M | $320.3M |
YoY Change | 8.09% | 7.42% | 1.88% |
Cashflow Statement
Concept | 2018 Q1 | 2017 Q4 | 2017 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $4.589M | $8.417M | $4.509M |
YoY Change | 1.77% | 22.11% | -56.39% |
Depreciation, Depletion And Amortization | $4.520M | $4.620M | $4.740M |
YoY Change | -4.64% | -2.94% | -3.07% |
Cash From Operating Activities | $10.24M | $18.68M | $5.054M |
YoY Change | 102.69% | 40.24% | -74.8% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $1.666M | -$5.250M | $1.670M |
YoY Change | -0.24% | -0.38% | -46.8% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$300.0K | $0.00 | |
YoY Change | -135.71% | -100.0% | |
Cash From Investing Activities | -$1.666M | -$5.550M | -$2.297M |
YoY Change | -27.47% | 25.57% | -44.93% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $1.615M | $1.304M | |
YoY Change | 23.85% | 106.98% | |
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -$1.615M | -190.0K | -$1.304M |
YoY Change | 23.85% | -24.0% | -20.0% |
NET CHANGE | |||
Cash From Operating Activities | $10.24M | 18.68M | $5.054M |
Cash From Investing Activities | -$1.666M | -5.550M | -$2.297M |
Cash From Financing Activities | -$1.615M | -190.0K | -$1.304M |
Net Change In Cash | $6.963M | 12.94M | $1.453M |
YoY Change | 379.22% | 49.6% | -89.8% |
FREE CASH FLOW | |||
Cash From Operating Activities | $10.24M | $18.68M | $5.054M |
Capital Expenditures | $1.666M | -$5.250M | $1.670M |
Free Cash Flow | $8.578M | $23.93M | $3.384M |
YoY Change | 153.49% | 28.73% | -79.99% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2017Q1 | apei |
Capitalized Program Development Costs And Other Assets
CapitalizedProgramDevelopmentCostsAndOtherAssets
|
627000 | USD |
CY2018Q1 | apei |
Capitalized Program Development Costs And Other Assets
CapitalizedProgramDevelopmentCostsAndOtherAssets
|
239000 | USD |
CY2017Q1 | apei |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
|
-500000 | USD |
CY2018Q1 | apei |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
|
-200000 | USD |
CY2018Q1 | apei |
Graduation Fee Per Degree
GraduationFeePerDegree
|
100 | USD |
CY2017Q1 | apei |
Instructional Costs And Expenses
InstructionalCostsAndExpenses
|
28956000 | USD |
CY2018Q1 | apei |
Instructional Costs And Expenses
InstructionalCostsAndExpenses
|
29686000 | USD |
CY2018Q1 | apei |
Number Of Days Of Bill Date To Receive Payment
NumberOfDaysOfBillDateToReceivePayment
|
P30D | |
CY2018Q1 | apei |
Number Of Students
NumberOfStudents
|
84700 | student |
CY2018Q1 | apei |
Number Of Subsidiaries
NumberOfSubsidiaries
|
2 | subsidiary |
CY2018Q1 | apei |
Percentage Of Students Served In Military On Active Duty At Time Of Initial Enrollment
PercentageOfStudentsServedInMilitaryOnActiveDutyAtTimeOfInitialEnrollment
|
0.54 | |
CY2018Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2018Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2018Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2018Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2018 | |
CY2018Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2018-03-31 | |
CY2018Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2018Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001201792 | |
CY2018Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
16399199 | shares |
CY2018Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
CY2018Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
AMERICAN PUBLIC EDUCATION INC | |
CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
8844000 | USD |
CY2018Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
4952000 | USD |
CY2017Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
7136000 | USD |
CY2018Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
7924000 | USD |
CY2017Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
13423000 | USD |
CY2018Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
15744000 | USD |
CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
180674000 | USD |
CY2018Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
180735000 | USD |
CY2017Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1246000 | USD |
CY2018Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1843000 | USD |
CY2017Q1 | us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
752000 | USD |
CY2018Q1 | us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
1353000 | USD |
CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
6276000 | USD |
CY2018Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
6181000 | USD |
CY2017Q4 | us-gaap |
Assets
Assets
|
339038000 | USD |
CY2018Q1 | us-gaap |
Assets
Assets
|
346231000 | USD |
CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
191133000 | USD |
CY2018Q1 | us-gaap |
Assets Current
AssetsCurrent
|
201501000 | USD |
CY2017Q4 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
0 | USD |
CY2018Q1 | us-gaap |
Capitalized Contract Cost Net
CapitalizedContractCostNet
|
0 | USD |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
146351000 | USD |
CY2017Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
147804000 | USD |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
179205000 | USD |
CY2018Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
186168000 | USD |
CY2017Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1453000 | USD |
CY2018Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
6963000 | USD |
CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2018Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2018Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2018Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
16268000 | shares |
CY2018Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
16399000 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
16268000 | shares |
CY2018Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
16399000 | shares |
CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
163000 | USD |
CY2018Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
164000 | USD |
CY2017Q4 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
0 | USD |
CY2018Q1 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
0 | USD |
CY2018Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
22000000 | USD |
CY2018Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
13000000 | USD |
CY2018Q1 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
9000000 | USD |
CY2017Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
67381000 | USD |
CY2018Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
68805000 | USD |
CY2017Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
2588000 | USD |
CY2018Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
850000 | USD |
CY2017Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
6281000 | USD |
CY2018Q1 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
7131000 | USD |
CY2018Q1 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
6180000 | USD |
CY2017Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
19374000 | USD |
CY2018Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
21957000 | USD |
CY2018Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
19753000 | USD |
CY2017Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
4744000 | USD |
CY2018Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
4522000 | USD |
CY2017Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.28 | |
CY2018Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.28 | |
CY2017Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.28 | |
CY2018Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.28 | |
CY2017Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.461 | |
CY2018Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.289 | |
CY2017Q1 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
494000 | USD |
CY2018Q1 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
490000 | USD |
CY2018Q1 | us-gaap |
Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
|
500000 | USD |
CY2017Q1 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-490000 | USD |
CY2018Q1 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-128000 | USD |
CY2017Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
17756000 | USD |
CY2018Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
18888000 | USD |
CY2017Q4 | us-gaap |
Goodwill
Goodwill
|
33899000 | USD |
CY2018Q1 | us-gaap |
Goodwill
Goodwill
|
33899000 | USD |
CY2017Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
8318000 | USD |
CY2018Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
6655000 | USD |
CY2017Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
40000 | USD |
CY2018Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-201000 | USD |
CY2017Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
3849000 | USD |
CY2018Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1865000 | USD |
CY2017Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
6052000 | USD |
CY2018Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-2016000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-3892000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-749000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
788000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-559000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
958000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-2783000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1870000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
2535000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
2305000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
4233000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
0 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2196000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2380000 | USD |
CY2017Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
11000 | USD |
CY2018Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
493000 | USD |
CY2017Q4 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
12481000 | USD |
CY2018Q1 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
12280000 | USD |
CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
49632000 | USD |
CY2018Q1 | us-gaap |
Liabilities
Liabilities
|
52452000 | USD |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
339038000 | USD |
CY2018Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
346231000 | USD |
CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
43351000 | USD |
CY2018Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
45321000 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1304000 | USD |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1615000 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2297000 | USD |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1666000 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
5054000 | USD |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
10244000 | USD |
CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4509000 | USD |
CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4589000 | USD |
CY2018Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | segment |
CY2018Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | segment |
CY2017Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
8307000 | USD |
CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
6162000 | USD |
CY2017Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
9151000 | USD |
CY2018Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
8304000 | USD |
CY2017Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-20000 | USD |
CY2018Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-38000 | USD |
CY2017Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
1402000 | USD |
CY2018Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2018Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2018Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
1615000 | USD |
CY2017Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1670000 | USD |
CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1427000 | USD |
CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2018Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2018Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2018Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2017Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
4792000 | USD |
CY2018Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
7409000 | USD |
CY2017Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
98000 | USD |
CY2018Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
92374000 | USD |
CY2018Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
90247000 | USD |
CY2017Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
2300000 | USD |
CY2018Q1 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
2000000 | USD |
CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
108569000 | USD |
CY2018Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
112880000 | USD |
CY2018Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
108291000 | USD |
CY2018Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
74967000 | USD |
CY2017Q1 | us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
75688000 | USD |
CY2018Q1 | us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
74967000 | USD |
CY2017Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
15435000 | USD |
CY2018Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
15581000 | USD |
CY2017Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1246000 | USD |
CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1843000 | USD |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
0 | shares |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.00 | |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
109616 | shares |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
109616 | shares |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
0 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
37.52 | |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.00 | |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.00 | |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
37.52 | |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.00 | |
CY2018Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | USD |
CY2018Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
||
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4D | |
CY2018Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
||
CY2018Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
289406000 | USD |
CY2018Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
293779000 | USD |
CY2017Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
1710000 | USD |
CY2018Q1 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
2668000 | USD |
CY2017Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
16320858 | shares |
CY2018Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
16534053 | shares |
CY2017Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
16190061 | shares |
CY2018Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
16359792 | shares |
CY2018Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nature of the Business</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">American Public Education, Inc., or APEI, which together with its subsidiaries is referred to as the “Company,” is a provider of online and campus-based postsecondary education to approximately </font><font style="font-family:inherit;font-size:10pt;">84,700</font><font style="font-family:inherit;font-size:10pt;"> students through </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> subsidiary institutions:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">American Public University System, Inc., or APUS, provides online postsecondary education directed primarily at the needs of the military, military-affiliated, and public service communities through American Military University, or AMU, and American Public University, or APU. APUS is regionally accredited by the Higher Learning Commission.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">National Education Seminars, Inc., which is referred to herein as Hondros College of Nursing, or HCN, provides nursing education to students at </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> campuses in Ohio, as well as online, to serve the needs of the nursing and healthcare communities. HCN is nationally accredited by the Accrediting Council of Independent Colleges and Schools, or ACICS, and the RN-to-BSN Program is accredited by the Commission on Collegiate Nursing Education. </font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s institutions are licensed or otherwise authorized, or are in the process of obtaining such licenses or authorizations, to offer postsecondary education programs by state authorities to the extent the institutions believe such licenses or authorizations are required, and are certified by the United States Department of Education, or ED, to participate in student financial aid programs authorized under Title IV of the Higher Education Act of 1965, as amended, or Title IV programs. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s operations are organized into </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> reportable segments:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">American Public Education Segment, or APEI Segment.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">This segment reflects the operational activities at APUS, other corporate activities, and minority investments.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Hondros College of Nursing Segment, or HCN Segment.</font><font style="font-family:inherit;font-size:10pt;"> This segment reflects the operational activities of HCN.</font></div></td></tr></table></div> | |
CY2018Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts in these unaudited interim Consolidated Financial Statements and accompanying notes. Actual results could differ from those estimates.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> |